释放潜力:热量限制,热量限制模仿,以及它们对癌症预防和治疗的影响
Ulises Edgardo De-Leon-Covarrubias1, Jose Juan Perez-Trujillo1, Sheila Adela Villa-Cedillo1
1Histology Department, Faculty of Medicine, Universidad Autonoma de Nuevo Leon (UANL), Monterrey 64460, Mexico.
Metabolites
|August 28, 2024
概括
热量限制 (CR) 和其模仿剂 (CRM) 在癌症治疗中表现有前途,因为它们可能延长寿命并降低癌症风险. 虽然在临床前研究中有效,但广泛使用需要更多的临床证据.
科学领域:
- 在瘤学瘤学.
- 代谢过程中的代谢.
- 药理学 药理学是指药理学的学科.
背景情况:
- 在临床前研究中,热量限制 (CR) 和其替代品显示出延长寿命和降低癌症风险的潜力.
- 对CR的临床试验结果不如临床前发现那么具有决定性.
- 卡路里限制模仿剂 (CRM) 为克服禁食限制提供了一个替代方案.
研究的目的:
- 审查关于CR和CRM在癌症治疗中的安全性和有效性的临床试验.
- 评估CR和CRM作为抗癌干预措施的潜力.
- 确定有希望的CRM来降低癌症风险.
主要方法:
- 对各种临床试验的系统审查.
- 评估饮食干预措施,如快速模仿饮食.
- 对药理学剂 (CRM) 的评估,包括甲胺和阿司匹林.
主要成果:
- 快速模仿饮食被很好地容忍,并减少了瘤生长标志物和化疗副作用.
- 一般来说,CRM的耐受性很好.
- 甲胺和阿司匹林在减少特定患者群体癌症风险方面表现出有希望的效果.
结论:
- 在抗癌疗法中,CR和CRM显示出有前途的效果.
- 需要进一步的研究来确定CR和CRM在标准治疗癌症治疗中的安全性和有效性.
- 饮食干预和特定的CRMs需要进一步研究它们在瘤学中的作用.
更多相关视频
相关概念视频
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K


